FinCanna Capital Corp Commences Trading on the Canadian Stock Exchange
FinCanna Capital Corp Commences Trading on the Canadian Stock Exchange
Not for distribution to United States newswire services or for dissemination in the United States.
Company Remains Focused on Sourcing and Funding Licensed Medical Cannabis Operations in California for
Royalties
VANCOUVER, British Columbia, Dec. 29, 2017 -- FinCanna Capital Corp. (“ FinCanna”) (CSE:CALI) FinCanna is pleased to
announce that the Company’s common shares will commence trading on the Canadian Securities Exchange (the “CSE”)
under the trading symbol “CALI” today, at 6:30AM PST on December 29, 2017.
FinCanna is supporting the greater medical use of cannabis while benefitting from the growth in the market by investing in top-
tier licensed medical cannabis companies in California. In exchange for financing, FinCanna will receive royalties from these
licensed medical cannabis and related operations.
To date, FinCanna has completed approximately $14M CDN in financing to support its flagship investment in Cultivation
Technologies (“CTI”). Based in Irvine, California, CTI is developing a very significant, state-of-the-art medical cannabis project
and has already secured permits to construct a fully-entitled, 111,500 sf. permitted medical cannabis facility on a six-acre
property in Coachella, Southern California.
Andriyko Herchak, CEO & Director, states, “We are very excited to be a part of the growing industry of licensed medical
cannabis, and our public listing offers investors increasing access to top-tier businesses in the United States, particularly
California. While the legalization of recreational cannabis is highly anticipated in California, we remain focused on our core
competency of sourcing and financing ethical and regulated companies operating in the licensed medical cannabis business
to leverage the paradigm shift in the industry.”
FinCanna is initially focused on California since it is the sixth largest economy in the world and the largest medical cannabis
market in North America. Analysts estimate the State’s legal cannabis industry will grow at a 21.1% CAGR to $6.5 billion by
2020, and generate upwards of $1 billion in tax revenue.
New laws that come into effect in January 2018 are expected to significantly change existing supply and demand dynamics.
About Cultivation Technologies
Cultivation Technologies, Inc. provides infrastructure, technology, and branding to the licensed medical cannabis industry. The
first major project for the company is in Coachella, California, which will span 6-acres featuring cultivation centers,
manufacturing facilities, a testing lab, a distribution hub, and a centralized processing center. For more information,
visit www.CultivationTech.com.
About FinCanna Capital Corp.
FinCanna is a royalty company for the licensed medical cannabis industry, with a focus on California. FinCanna, led by a team
of finance and industry experts is building its portfolio of investments in scalable, best-in-class projects. FinCanna’s flagship
investment is with Cultivation Technologies Inc. to provide funding for its fully-entitled, large-scale indoor medical cannabis
facility to be developed in Coachella, Southern California. This Coachella Campus will be a state-of-the-art facility that will
include cultivation, extraction, manufacturing, testing and distribution. For additional information visit www.fincannacapital.com.
FinCanna Capital Corp.
Andriyko Herchak, CEO & Director
Investor Relations:
Arlen Hansen
Kin Communications
1-866-684-6730
Forward-Looking Information
Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-
looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often
address expected future business and financial performance, and often contain words such as "anticipate", "believe", "plan",
"estimate", "expect", and "intend", statements that an action or event "may", "might", "could", "should", or "will" be taken or
occur, or other similar expressions. Forward-looking statements include, but are not limited to the growth in the cannabis
market, the size of revenue of the cannabis market, the construction of CTI’s medical cannabis facility in Coachella,
Southern California (“Coachella Campus”), the ability of FinCanna to raise financing to invest in additional projects, FinCanna’s
financial forecasts, plans for expansion of FinCanna’s business, statements about potential market developments and trends
and other statements that are not historical facts. In addition, forward-looking statements relating to CTI’s business are based
on assumptions regarding the construction, completion and operations of CTI’s Coachella Campus, including that CTI will
obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required to
operate the facility, that construction is completed on time and budget, while CTI is allowed to operate on an interim basis with
its existing permits, that CTI obtains state licenses to operate on a permanent basis and that the equipment used in the
cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests. By their nature, forward-
looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results,
performance or achievements, or other future events, to be materially different from any future results, performance or
achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks
identified in the CSE listing statement and other reports and filings with the applicable Canadian securities regulators. Forward
-looking statements are made based on management's beliefs, estimates and opinions on the date that statements are made
and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and
opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned
against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise
forward-looking information to reflect new events or circumstances unless required by applicable law.